Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Non-Steroidal Anti-inflammatory Drugs Market from 2024 to 2025?

The market size for non-steroidal anti-inflammatory drugs has seen robust growth in recent years. It is predicted to increase from a value of $20.68 billion in 2024 to $22.1 billion in 2025, marking a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historical period can be traced to chronic inflammatory conditions, the management of pain after surgery, sports-related injuries, over-the-counter accessibility, an aging demographic, and increasing consumer awareness.

What Is the Projected Market Size of the Non-Steroidal Anti-inflammatory Drugs Market?

In the coming years, the non-steroidal anti-inflammatory drugs market is predicted to experience impressive growth, expanding to $28.79 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period can be credited to the introduction of new pain management therapies, amendments in regulations, the use of telehealth, global wellness fads, competition in the biosimilar market, patient choices, and the implementation of precision medicine strategies. The forecast period is also expected to witness prominent trends such as dominance of the over-the-counter (OTC) market, a surge in preference for cox-2 inhibitors, generics and market competition, and the merging of digital health technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Who are the Major Competitors in the Non-Steroidal Anti-inflammatory Drugs Market Outlook?

Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

What Is Fueling Growth in the Non-Steroidal Anti-inflammatory Drugs Market?

The increasing prevalence of chronic pain is anticipated to stimulate the expansion of the non-steroidal anti-inflammatory drugs market. The term chronic pain describes discomfort that lasts for over six months. Non-steroidal anti-inflammatory drugs are utilized to repair injuries and alleviate chronic pain. For example, the CDC (Centers for Disease Control and Prevention), a government agency based in the US, reported in April 2022 that arthritis was a frequent cause of chronic pain, affecting millions of US citizens. Roughly one out of four adults, or 15 million people, with arthritis are suffering from intense joint pain related to arthritis. Consequently, the escalating prevalence of chronic pain is propelling the growth of the non-steroidal anti-inflammatory drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Which Non-Steroidal Anti-inflammatory Drugs Market Segments Are Growing the Fastest?

The non-steroidal anti-inflammatory drugs market covered in this report is segmented –

1) By Route Of Administration: Oral, Topical, Other Route Of Administration

2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Oral: Tablets, Capsules, Liquids Or Solutions

2) By Topical: Gels, Creams, Patches

3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

Which Industry Trends Are Shaping the Future of the Non-Steroidal Anti-inflammatory Drugs Market?

One of the primary ongoing tendencies in the market for non-steroidal anti-inflammatory drugs is significant product innovation. The key players in this market are highly focused on inventing new technology solutions. In an example from March 2024, the pharmaceutical company based in Ireland, Endo International plc, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. They feature a combination of the pain-relieving and anti-inflammatory benefits of ibuprofen along with the stomach shielding effects of famotidine. The aim of this concoction is to ease pain, while simultaneously reducing the probability of gastrointestinal side effects common with the extensive use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Which Countries Are Leading the Non-Steroidal Anti-inflammatory Drugs Market?

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023

This Report Delivers Insight On:

1. How big is the non-steroidal anti-inflammatory drugs market, and how is it changing globally?

2. Who are the major companies in the non-steroidal anti-inflammatory drugs market, and how are they performing?

3. What are the key opportunities and risks in the non-steroidal anti-inflammatory drugs market right now?

4. Which products or customer segments are growing the most in the non-steroidal anti-inflammatory drugs market?

5. What factors are helping or slowing down the growth of the non-steroidal anti-inflammatory drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model